Gumbohatch

Country: European Union

Language: Estonian

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

live nõrgenenud nakkushaiguste bursal haiguse viiruse (IBDV), tüvi 1052

Available from:

Laboratorios Hipra, S.A.

ATC code:

QI01AD09

INN (International Name):

avian infectious bursal disease vaccine (live)

Therapeutic group:

Chicken; Embryonated chicken eggs

Therapeutic area:

Immunoloogilised ravimid jaoks linnud, kodukana, Live viral vaccines, lindude nakkav bursal haiguse viiruse (gumboro haigus)

Therapeutic indications:

Aktiivse immuniseerimise 1-ühepäevased tibud, broiler ja embryonated broiler kanamunad, et vähendada kliinilisi tunnuseid ja kahjustused on bursa kohta Fabricius, mis on põhjustatud väga virulent lindude nakkav bursal haiguse viirus.

Product summary:

Revision: 2

Authorization status:

Volitatud

Authorization date:

2019-11-12

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Selle veterinaarravimi ajakohane teave on veterinaarravimite teabe
veebilehel.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Selle veterinaarravimi ajakohane teave on veterinaarravimite teabe
veebilehel.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 15-02-2024
Public Assessment Report Public Assessment Report Bulgarian 15-02-2024
Patient Information leaflet Patient Information leaflet Spanish 15-02-2024
Public Assessment Report Public Assessment Report Spanish 15-02-2024
Patient Information leaflet Patient Information leaflet Czech 15-02-2024
Public Assessment Report Public Assessment Report Czech 15-02-2024
Patient Information leaflet Patient Information leaflet Danish 15-02-2024
Public Assessment Report Public Assessment Report Danish 15-02-2024
Patient Information leaflet Patient Information leaflet German 15-02-2024
Public Assessment Report Public Assessment Report German 15-02-2024
Patient Information leaflet Patient Information leaflet Greek 15-02-2024
Public Assessment Report Public Assessment Report Greek 15-02-2024
Patient Information leaflet Patient Information leaflet English 15-02-2024
Public Assessment Report Public Assessment Report English 15-02-2024
Patient Information leaflet Patient Information leaflet French 15-02-2024
Public Assessment Report Public Assessment Report French 15-02-2024
Patient Information leaflet Patient Information leaflet Italian 15-02-2024
Public Assessment Report Public Assessment Report Italian 15-02-2024
Patient Information leaflet Patient Information leaflet Latvian 15-02-2024
Public Assessment Report Public Assessment Report Latvian 15-02-2024
Patient Information leaflet Patient Information leaflet Lithuanian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 15-02-2024
Public Assessment Report Public Assessment Report Lithuanian 15-02-2024
Patient Information leaflet Patient Information leaflet Hungarian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 15-02-2024
Public Assessment Report Public Assessment Report Hungarian 15-02-2024
Patient Information leaflet Patient Information leaflet Maltese 15-02-2024
Public Assessment Report Public Assessment Report Maltese 15-02-2024
Patient Information leaflet Patient Information leaflet Dutch 15-02-2024
Public Assessment Report Public Assessment Report Dutch 15-02-2024
Patient Information leaflet Patient Information leaflet Polish 15-02-2024
Public Assessment Report Public Assessment Report Polish 15-02-2024
Patient Information leaflet Patient Information leaflet Portuguese 15-02-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 15-02-2024
Public Assessment Report Public Assessment Report Portuguese 15-02-2024
Patient Information leaflet Patient Information leaflet Romanian 15-02-2024
Public Assessment Report Public Assessment Report Romanian 15-02-2024
Patient Information leaflet Patient Information leaflet Slovak 15-02-2024
Public Assessment Report Public Assessment Report Slovak 15-02-2024
Patient Information leaflet Patient Information leaflet Slovenian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 15-02-2024
Public Assessment Report Public Assessment Report Slovenian 15-02-2024
Patient Information leaflet Patient Information leaflet Finnish 15-02-2024
Public Assessment Report Public Assessment Report Finnish 15-02-2024
Patient Information leaflet Patient Information leaflet Swedish 15-02-2024
Public Assessment Report Public Assessment Report Swedish 15-02-2024
Patient Information leaflet Patient Information leaflet Norwegian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 15-02-2024
Public Assessment Report Public Assessment Report Norwegian 15-02-2024
Patient Information leaflet Patient Information leaflet Icelandic 15-02-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 15-02-2024
Public Assessment Report Public Assessment Report Icelandic 15-02-2024
Patient Information leaflet Patient Information leaflet Croatian 15-02-2024
Public Assessment Report Public Assessment Report Croatian 15-02-2024
Patient Information leaflet Patient Information leaflet Irish 15-02-2024
Public Assessment Report Public Assessment Report Irish 15-02-2024

View documents history